Select Publications
Journal articles
2019, 'Cutaneous leishmaniasis: A neglected disfiguring disease for women', International Journal of Women's Dermatology, 5, pp. 158 - 165, http://dx.doi.org/10.1016/j.ijwd.2019.01.002
,2019, 'Introduction to The Art of Prevention series', International Journal of Women's Dermatology, 5, pp. 151, http://dx.doi.org/10.1016/j.ijwd.2019.05.004
,2019, 'Pathogenesis and clinical features of alopecia in epidermolysis bullosa: A systematic review', Pediatric Dermatology, 36, pp. 430 - 436, http://dx.doi.org/10.1111/pde.13866
,2019, 'Pemphigus vulgaris accompanied with amyotrophic lateral sclerosis: a rare coincidence or pathogenic relationship?', European Journal of Dermatology, 29, pp. 435 - 436, http://dx.doi.org/10.1684/ejd.2019.3577
,2019, 'Successful management of bullous pemphigoid with dimethyl fumarate therapy: A case report', International Journal of Women's Dermatology, 5, pp. 179 - 180, http://dx.doi.org/10.1016/j.ijwd.2019.02.001
,2019, 'Is it psoriasis, a virus, or fungal infection?', Australian Doctor
,2019, 'Pharmacological advances in pemphigus', Current Opinion in Pharmacology, 46, pp. 44 - 49, http://dx.doi.org/10.1016/j.coph.2019.01.001
,2019, 'Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: Final update of the pivotal ERIVANCE BCC study (BMC Cancer. (2017) 17 (332) DOI: 10.1186/s12885-017-3286-5)', BMC Cancer, 19, http://dx.doi.org/10.1186/s12885-019-5568-6
,2019, 'Quality of life in turkish patients with autoimmune blistering diseases: Reliability and validity of the autoimmune bullous disease quality of life and the treatment of autoimmune bullous disease quality of life questionnaires', Turkish Journal of Dermatology, 13, pp. 83 - 90, http://dx.doi.org/10.4103/tjd.tjd_16_19
,2019, 'Association between bullous pemphigoid and psoriasis: Systematic review and meta-analysis of case-control studies', Australasian Journal of Dermatology, 60, pp. 23 - 28, http://dx.doi.org/10.1111/ajd.12899
,2019, 'Diagnostic Criteria and Phenotypes of Pemphigoid and the Association with Gliptins', JAMA Dermatology, 155, pp. 147 - 148, http://dx.doi.org/10.1001/jamadermatol.2018.4847
,2019, 'Epidermolysis Bullosa Patients' Perception of Surgical Wound and Scar Healing', Dermatologic Surgery, 45, pp. 280 - 289, http://dx.doi.org/10.1097/DSS.0000000000001673
,2019, 'A new indirect immunofluorescence BIOCHIP method for the serological diagnosis of bullous pemphigoid: A review of literature', Australasian Journal of Dermatology, 60, pp. e173 - e177, http://dx.doi.org/10.1111/ajd.13034
,2019, 'Editorial: Skin blistering diseases', Frontiers in Medicine, 6, http://dx.doi.org/10.3389/fmed.2019.00060
,2019, 'Large International Validation of ABSIS and PDAI Pemphigus Severity Scores', Journal of Investigative Dermatology, 139, pp. 31 - 37, http://dx.doi.org/10.1016/j.jid.2018.04.042
,2019, 'Pemphigus vulgaris disease activity: The role of antibodies to desmogleins and their isotype', Journal of Oral Pathology and Medicine, 48, pp. 619 - 625, http://dx.doi.org/10.1111/jop.12913
,2019, 'Assessment of the quality of life of Egyptian and Tunisian autoimmune bullous diseases' patients using an Arabic version of the autoimmune bullous disease quality of life and the treatment of autoimmune bullous disease quality of life questionnaires.', An Bras Dermatol, 94, pp. 399 - 404, http://dx.doi.org/10.1590/abd1806-4841.20197198
,2019, 'Comment les experts internationaux traitent-ils les patients atteints de pemphigoïde bulleuse à travers le monde ?', Annales de Dermatologie et de Vénéréologie, 146, pp. A62 - A62, http://dx.doi.org/10.1016/j.annder.2019.09.039
,2019, 'Corrélations entre les questionnaires de qualité de vie spécifiques aux maladies bulleuses auto-immunes ABQOL et TABQOL, et les scores de sévérité objectifs', Annales de Dermatologie et de Vénéréologie, 146, pp. A97 - A98, http://dx.doi.org/10.1016/j.annder.2019.09.100
,2019, 'Multiple milia formation in blistering diseases', International Journal of Women's Dermatology, 5, pp. 275 - 275, http://dx.doi.org/10.1016/j.ijwd.2019.06.004
,2018, 'Probiotics for treating eczema', Cochrane Database of Systematic Reviews, 2018, http://dx.doi.org/10.1002/14651858.CD006135.pub3
,2018, 'The effect of autoimmune blistering diseases on work productivity', Journal of the European Academy of Dermatology and Venereology, 32, pp. 1959 - 1966, http://dx.doi.org/10.1111/jdv.15062
,2018, 'Is the Oral Disease Severity Score going to be useful for dermatologists when assessing pemphigus?', British Journal of Dermatology, 179, pp. 816 - 817, http://dx.doi.org/10.1111/bjd.16911
,2018, 'Normocomplementaemic urticarial vasculitis: Effective treatment with omalizumab', Clinical and Translational Allergy, 8, http://dx.doi.org/10.1186/s13601-018-0222-y
,2018, 'Pemphigoid gestationis and intravenous immunoglobulin therapy', International Journal of Women's Dermatology, 4, pp. 166 - 169, http://dx.doi.org/10.1016/j.ijwd.2018.03.007
,2018, 'The effects of autoimmune blistering diseases on work productivity: A review', International Journal of Women's Dermatology, 4, pp. 131 - 138, http://dx.doi.org/10.1016/j.ijwd.2017.11.001
,2018, 'APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa', Science Translational Medicine, 10, http://dx.doi.org/10.1126/scitranslmed.aas9668
,2018, 'Chinese version of the treatment of autoimmune bullous disease quality of life questionnaire: Reliability and validity', Indian Journal of Dermatology, Venereology and Leprology, 84, pp. 431 - 436, http://dx.doi.org/10.4103/ijdvl.IJDVL_538_16
,2018, 'International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita', British Journal of Dermatology, 179, pp. 30 - 41, http://dx.doi.org/10.1111/bjd.16138
,2018, 'New biochip immunofluorescence test for the serological diagnosis of pemphigus vulgaris and foliaceus: A review of the literature', International Journal of Women's Dermatology, 4, pp. 102 - 108, http://dx.doi.org/10.1016/j.ijwd.2017.10.001
,2018, 'A review of scoring systems for ocular involvement in chronic cutaneous bullous diseases', Orphanet Journal of Rare Diseases, 13, http://dx.doi.org/10.1186/s13023-018-0823-5
,2018, 'Osteopenia is common in mild forms of epidermolysis bullosa', JOURNAL OF INVESTIGATIVE DERMATOLOGY, 138, pp. S45 - S45, http://dx.doi.org/10.1016/j.jid.2018.03.271
,2018, 'Reliability of the BIOCHIP in pemphigus and pemphigoid patients the evaluations of blistering disease experts', JOURNAL OF INVESTIGATIVE DERMATOLOGY, 138, pp. S10 - S10, http://dx.doi.org/10.1016/j.jid.2018.03.063
,2018, 'Mucous membrane pemphigoid affecting the epiglottis and response to intravenous immunoglobulin therapy', Otolaryngology Case Reports, 6, pp. 1 - 3, http://dx.doi.org/10.1016/j.xocr.2017.11.001
,2018, 'Psychosocial impact of inherited and autoimmune blistering diseases', International Journal of Women's Dermatology, 4, pp. 49 - 53, http://dx.doi.org/10.1016/j.ijwd.2017.11.004
,2018, 'Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement', British Journal of Dermatology, 178, pp. 768 - 775, http://dx.doi.org/10.1111/bjd.15928
,2018, 'Use of an Investigator's Global Assessment Scale to Evaluate Disease Severity in Patients swith Epidermolysis Bullosa Simplex', SKIN The Journal of Cutaneous Medicine, 2, pp. S55 - S55, http://dx.doi.org/10.25251/skin.2.supp.55
,2018, 'Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management', Clinical Reviews in Allergy and Immunology, 54, pp. 26 - 51, http://dx.doi.org/10.1007/s12016-017-8633-4
,2018, 'A case report of the use of rituximab and the epidermolysis bullosa disease activity scoring index (EBDASI) in a patient with epidermolysis bullosa acquisita with extensive esophageal involvement', Acta Dermatovenerologica Croatica, 26, pp. 325 - 328
,2018, 'Epidemiology and outcome of squamous cell carcinoma in epidermolysis bullosa in Australia and New Zealand', Acta Dermato-Venereologica, 98, pp. 70 - 76, http://dx.doi.org/10.2340/00015555-2781
,2018, 'Perspective from the 5th international pemphigus and pemphigoid foundation scientific conference', Frontiers in Medicine, 5, http://dx.doi.org/10.3389/fmed.2018.00306
,2018, '585 Natural history of wound closure and other clinical endpoints in epidermolysis bullosa: Lessons from a 90-day multicenter trial', Journal of Investigative Dermatology, 138, pp. S99 - S99, http://dx.doi.org/10.1016/j.jid.2018.03.593
,2018, 'International chapters and membership of WDS are growing', International Journal of Women's Dermatology, 4, pp. 240 - 240, http://dx.doi.org/10.1016/j.ijwd.2018.10.005
,2018, 'LB1509 Anti-desmoglein levels & response to the BTK inhibitor PRN1008 in pemphigus', Journal of Investigative Dermatology, 138, pp. B7 - B7, http://dx.doi.org/10.1016/j.jid.2018.06.040
,2018, 'Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement', British Journal of Dermatology, 178, pp. e232 - e232, http://dx.doi.org/10.1111/bjd.16385
,2018, '对过敏性皮肤炎使用全身用糖皮质激素:国际湿疹理事会共识声明', British Journal of Dermatology, 178, pp. e246 - e246, http://dx.doi.org/10.1111/bjd.16452
,2017, 'Disease-specific health related quality of life patient reported outcome measures in Genodermatoses: A systematic review and critical evaluation', Orphanet Journal of Rare Diseases, 12, http://dx.doi.org/10.1186/s13023-017-0739-5
,2017, 'A study of the number of female editors-in-chief of dermatology journals', International Journal of Women's Dermatology, 3, pp. 185 - 188, http://dx.doi.org/10.1016/j.ijwd.2017.03.001
,2017, 'New developments in the management of congenital epidermolysis bullosa', Annales de Dermatologie et de Venereologie, 144, pp. S6 - S7, http://dx.doi.org/10.1016/j.annder.2017.09.587
,2017, 'Rituximab and short-course prednisone as the new gold standard for new-onset pemphigus vulgaris and pemphigus foliaceus', British Journal of Dermatology, 177, pp. 1143 - 1144, http://dx.doi.org/10.1111/bjd.15947
,